Sandwich and Half-Sandwich Derivatives of Platensimycin: Synthesis and Biological Evaluation
Journal article, 2012

The multistep synthesis and biological evaluation of five structurally diverse, chiral and achiral CpMn(CO)3 (4, 7 and 8), (η6-arene)Cr(CO)3 (5), and [3]ferrocenophane-1-one (6) containing platensimycin (1) derivatives are described in this report. The structures were inspired by the antibiotic platensimycin. All the chiral compounds presented in this report are racemates. The new compounds were unambiguously characterized by 1H and 13C NMR spectroscopy, mass spectrometry, IR spectroscopy, and elemental analysis and in certain cases by X-ray crystallography (4, 16, 18, and 29). The antibacterial and antitumor activity of selected derivatives was tested. Molecular modeling suggests that the derivatives described here may well fit into the active site of the FabF enzyme, which is the biological target of platensimycin. Hence, the antimicrobial activities of our new bioorganometallices 4–8 and the protected amide intermediates 15, 17, 18, 23, 28, 29, and 31 were tested against various Gram-positive and Gram-negative bacterial strains. However, all compounds were inactive up to concentrations of 180 μg/mL. The cytotoxicity of compounds 4 and 6 and the protected amide intermediates 15, 17, 18, 23, 28, 29, and 31 was tested against HepG2 and PT45 mammalian cancer cell lines. Surprisingly, all compounds containing a trimethylsilylethyl ester functionality at the aromatic ring (17, 23, 29, and 31) displayed rather high cytotoxicity between 2 and 9 μM.

Author

Malay Patra

Ruhr-Universität Bochum

Gilles Gasser

University of Zürich

Michaela Wenzel

Ruhr-Universität Bochum

Klaus Merz

Ruhr-Universität Bochum

Julia E. Bandow

Ruhr-Universität Bochum

Nils Metzler-Nolte

Ruhr-Universität Bochum

Organometallics

0276-7333 (ISSN) 1520-6041 (eISSN)

Vol. 31 16 5760-5771

Subject Categories (SSIF 2025)

Inorganic Chemistry

Pharmaceutical Sciences

Organic Chemistry

Medicinal Chemistry

DOI

10.1021/om201146c

More information

Latest update

3/25/2026